(Q74465030)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Quality assessment of glycopeptide susceptibility tests: a European collaborative study. European Glycopeptide Resistance Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

ORCID Public Data File 2021

author name string

D F Brown

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

P Courvalin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Antimicrobial Agents

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

153-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

Current perspectives on glycopeptide resistance.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Glycopeptide resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Teicoplanin-resistant coagulase-negative staphylococcus.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Emergence of teicoplanin-resistant coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Cystitis due to vancomycin-intermediate Staphylococcus saprophyticus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

In vitro detection of enterococcal vancomycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Detection of vancomycin resistance in Enterococcus species

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Detection of vancomycin resistance in enterococci by the Vitek AMS system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Evaluation of the teicoplanin broth microdilution and disk diffusion susceptibility tests and recommended interpretive criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Impact of the agar medium and disc type on disc diffusion susceptibility testing against teicoplanin and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Evaluation of the Epsilometer test (E test) for testing the susceptibility of coagulase-negative staphylococci to teicoplanin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Development of a standardized screening method for detection of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900047-2

7 January 2021

10.1016/S0924-8579(97)00047-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552711%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference